116
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma

, , , &
Pages 4403-4416 | Published online: 01 Jun 2021

References

  • Shi HA , Ng CWB , Kwa CT , Sim QXC . Ameloblastoma: a succinct review of the classification, genetic understanding and novel molecular targeted therapies. Surgeon . 2020. doi:10.1016/j.surge.2020.06.009
  • Mendenhall WM , Werning JW , Fernandes R , Malyapa RS , Mendenhall NP . Ameloblastoma. Am J Clin Oncol . 2007;30(6):645–648. doi:10.1097/COC.0b013e3181573e59 18091060
  • Effiom OA , Ogundana OM , Akinshipo AO , Akintoye SO . Ameloblastoma: current etiopathological concepts and management. Oral Dis . 2018;24(3):307–316. doi:10.1111/odi.12646 28142213
  • Lee SK , Kim YS . Current concepts and occurrence of epithelial odontogenic tumors: i. ameloblastoma and adenomatoid odontogenic tumor. Korean J Pathol . 2013;47(3):191–202. doi:10.4132/KoreanJPathol.2013.47.3.191 23837011
  • El-Naggar AK , Chan JKC , Grandis JR , Takata T , Slootweg PJ . WHO Classification of Head and Neck Tumours. Odontogenic and Maxillofacial Bone Tumors . Lyon, France: IARC Press; 2017.
  • Neagu D , Escuder-de la Torre O , Vázquez-Mahía I , et al. Surgical management of ameloblastoma. Review of literature. J Clin Exp Dent . 2019;11(1):e70–e75. doi:10.4317/jced.55452 30697397
  • Hendra FN , Kalla DSN , Van Cann EM , de Vet HCW , Helder MN , Forouzanfar T . Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis. Oral Dis . 2019;25(7):1683–1696. doi:10.1111/odi.13014 30548549
  • Au SW , Li KY , Choi WS , Su YX . Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg . 2019;48(10):1300–1306. doi:10.1016/j.ijom.2019.04.008 31084977
  • Yang R , Liu Z , Gokavarapu S , Peng C , Ji T , Cao W . Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma. Chin J Cancer Res . 2017;29(3):189–195. doi:10.21147/j.issn.1000-9604.2017.03.04 28729769
  • Moons KG , Altman DG , Vergouwe Y , Royston P . Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ . 2009;338:b606. doi:10.1136/bmj.b606 19502216
  • Gu HQ , Liu C . Clinical prediction models: evaluation matters. Ann Transl Med . 2020;8(4):72. doi:10.21037/atm.2019.11.143 32175365
  • Balachandran VP , Gonen M , Smith JJ , DeMatteo RP . Nomograms in oncology: more than meets the eye. Lancet Oncol . 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-7 25846097
  • Hippisley-Cox J , Coupland C , Brindle P . Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ . 2017;357.
  • Tang XR , Li YQ , Liang SB , et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol . 2018;19(3):382–393. doi:10.1016/S1470-2045(18)30080-9 29428165
  • Montero PH , Yu CH , Palmer FL , et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer . 2014;120(2):214–221. doi:10.1002/cncr.28407 24399417
  • Pleijhuis RG , Kwast ABG , Jansen L , et al. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast . 2013;22(5):773–779. doi:10.1016/j.breast.2013.01.010 23462681
  • Liang W , Zhang L , Jiang G , et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol . 2015;33(8):861–869. doi:10.1200/JCO.2014.56.6661 25624438
  • Murtaugh PA . In defense of P values. Ecology . 2014;95(3):611–617. doi:10.1890/13-0590.1 24804441
  • Harrell FE Jr , Califf RM , Pryor DB , Lee KL , Rosati RA . Evaluating the yield of medical tests. JAMA . 1982;247(18):2543–2546. doi:10.1001/jama.1982.03320430047030 7069920
  • Camp RL , Dolled-Filhart M , Rimm DL . X-Tile. Clin Cancer Res . 2004;10(21):7252. doi:10.1158/1078-0432.CCR-04-0713 15534099
  • Ledesma-Montes C , Mosqueda-Taylor A , Carlos-Bregni R , et al. Ameloblastomas: a regional Latin-American multicentric study. Oral Dis . 2007;13(3):303–307. doi:10.1111/j.1601-0825.2006.01284.x 17448213
  • Reichart PA , Philipsen HP , Sonner S . Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol . 1995;31b(2):86–99.7633291
  • McClary AC , West RB , McClary AC , et al. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol . 2016;273(7):1649–1661. doi:10.1007/s00405-015-3631-8 25926124
  • Olaltan AA , Arole G , Adekeye EO . Recurrent ameloblastoma of the jaws: a follow-up study. Int J Oral Maxillofac Surg . 1998;27(6):456–460. doi:10.1016/S0901-5027(98)80037-4 9869287
  • Barnes L , Eveson JW , Reichart P . World Health Organization Classification of Tumours. Pathology and Genetics of the Head and Neck Tumours . Lyon, France: IARC Press; 2005:283–327.
  • Chrcanovic BR , Gomes CC , Dos Santos TR , Abreu M , Gomez RS . Clinical factors associated with the recurrence of central giant cell lesions. J Oral Pathol Med . 2019;48(9):799–802. doi:10.1111/jop.12937 31353534
  • Kramer IRH , Pindborg JJ . WHO Histological Typing ofOdontogenic Tumours . 2nd ed. Geneva: Springer-Verlag; 1992.
  • Hong J , Yun PY , Chung IH , et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg . 2007;36(4):283–288. doi:10.1016/j.ijom.2006.11.003 17222535
  • Milman T , Ying GS , Pan W , LiVolsi V . Ameloblastoma: 25 year experience at a single institution. Head Neck Pathol . 2016;10(4):513–520. doi:10.1007/s12105-016-0734-5 27272180